Test Code LAB23 Digoxin, Plasma or Serum
Reporting Title
Digoxin
Methodology
Roche Diagnostics, Electrochemiluminescence Immunoassay- RMH, GMC, DH, DMH, GMH, WECC, PMC, GCMH, BH, OBH, MGH, MH, HMH, SH
Digoxin is prescribed for treatment of congestive heart failure and cardiac rhythm disturbances.
VWH Lab Only:
DIGN reagent, when used in conjunction with SYNCHRON LX® System(s), UniCel® DxC 860i System(s) and SYNCHRON® Systems Drug Calibrator 2 set, is intended for quantitative determination of total Digoxin concentration in human serum or plasma.
Performing Laboratory
OhioHealth Laboratory Services- RMH,GMC, DH, DMH, MGH, GMH, HMH, WECC, PMH, OBH, MH, SH, GCMH, BH and VWH Core Laboratories
Specimen Requirements
Collection Instructions:
1. Serum and Plasma gel tubes should be centrifuged within 2 hours of collection.
2. Red-top tubes should be centrifuged and aliquoted within 2 hours of collection.
Due to interference, patients receiving high doses of biotin (>5 mg/day) should wait at least 8 hours after dose before having blood drawn.
Submit only 1 of the following specimens:
Preferred:
Serum
Draw blood in a gold-top or a speckled-top serum gel tube(s). Spin down and send 1 mL of serum refrigerated. Specimen for a trough level should be drawn 8 hours after completion of infusion of an intravenous dose or 12 hours after an oral dose.
Note: 1. Plain, red-top tube(s) is also acceptable.
2. Patients receiving therapy with mouse monoclonal antibodies may have erroneous results.
3. Indicate serum on request form.
4. Label specimen appropriately (serum).
Alternate (Preferred for VWH Lab):
Plasma
Draw blood in a mint green-top (heparin) gel tube(s). Spin down and send 1 mL of heparinized plasma refrigerated. Specimen for a trough level should be drawn 8 hours after completion of infusion of an intravenous dose or 12 hours after an oral dose.
Note:
1. Patients receiving therapy with mouse monoclonal antibodies may have erroneous results.
2. Indicate plasma on request form.
3. Label specimen appropriately (plasma).
VWH Lab:
4. Tubes of blood are to be kept closed at all times and in a vertical position. It is recommended that the serum or plasma be physically separated from contact with cells within two hours from the time of collection.
5. Separated serum or plasma should not remain at room temperature longer than 8 hours. If assays are not completed within 8 hours, serum or plasma should be stored at +2°C to +8°C. Refrigerated samples are stable for 48 hrs.
Roche Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Serum or plasma | Refrigerated | 14 days |
Ambient | 7 days | |
Frozen | 6 months |
Specimen Transport Temperature
Refrigerate/Ambient/Frozen ok
Reference Values
Therapeutic concentration: 0.5-2.2 ng/mL
Critical value >2.5 ng/mL
Alerting category: Always called within 1 hour
Note: 1. Digoxin-like immunoreactive substances have been identified in patients with renal or liver failure and third trimester pregnancy. These may cause falsely elevated results.
2. Patients receiving Digoxin Immune FAb will have erroneous results.
3. DigibindTM, digitoxin, digoxigenin, nabumetone, and uzara may cause falsely elevated results.
VWH Lab Only:
Therapeutic | Serum/Plasma (Congestive heart failure) | 0.8 – 1.5 ng/mL |
Serum/Plasma (Arrhythmias) | 1.5 – 2.0 ng/mL | |
Toxic | Serum or Plasma (Adult) | > 2.5 ng/mL |
Serum or Plasma (Child) | > 3.0 ng/mL |
Day(s) Test Set Up
Monday through Sunday; Continuously
Test Classification and CPT Coding
80162